Found 24 matching trials
Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease
PHASE3An open label extension to the RHB-104-01 Study....
Location
Digestive Care Associates, Inc., 1000 Laurel Street
Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
PHASE3The aim of this study is to determine the effectiveness of rifabutin triple...
Location
Multiple Locations
Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.
PHASE3The aim of our study will be to assess in an open-label, multicenter, rando...
The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin Resistance
PHASE4Background: Mycobacterium abscessus, one of the most common species of nont...
Location
National Taiwan University Hospital
Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease
PHASE4To determine the safety and tolerance of clarithromycin given three times p...
Location
The University of Texas Health Science Center at Tyler
Patients Response to Early Switch To Oral:Osteomyelitis Study
EARLY_PHASE1Based on the current literature, investigators hypothesize that patients wi...
Location
University of Louisville
Enhanced Treatment Strategy for Disseminated MAC Infection in HIV Patients: A Randomized Controlled Trial
NABackground:
Disseminated Mycobacterium avium complex (MAC) infection remai...
Location
Multiple Locations
Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.
PHASE4This study aims to investigate the efficacy of a 7-day genotypic resistance...
Location
Konstantopoulio-Patision General Hospital
RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
PHASE3A 2-part multi-center, Phase 3, randomized, double-blind, placebo-controlle...
Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)
PHASE2The investigators hypothesize that Mycobacterium avium paratuberculosis pos...
Location
RedHill MS Clinical Trial Site 002